AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « das »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
dark < das < data  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000008 (2010) P. Roll [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H.-P. Tony [Allemagne]Tocilizumab
000013 (2013) Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse]Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis
000015 (2013) Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000048 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000083 (2012) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000094 (2011) Maasa Hama [Japon] ; Takeaki Uehara [Japon] ; Kaoru Takase [Japon] ; Atsushi Ihata [Japon] ; Atsuhisa Ueda [Japon] ; Mitsuhiro Takeno [Japon] ; Kazuya Shizukuishi [Japon] ; Ukihide Tateishi [Japon] ; Yoshiaki Ishigatsubo [Japon]Power Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab—preliminary data
000133 (2009) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000143 (2012) Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000147 (2010) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Hiromi Hagiwara [Japon] ; Akihiro Narita [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Tatsuya Atsumi [Japon] ; Hiroki Shirato [Japon] ; Satoshi Terae [Japon]Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger
000154 (2011) Atsushi Kaneko [Japon] ; Daihei Kida [Japon] ; Kiwamu Saito [Japon] ; Masami Tsukamoto [Japon] ; Tomotaro Sato [Japon]Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI
000240 (2013) Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
000294 (2013) Shunsei Hirohata [Japon] ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon] ; Masahisa Kyogoku [Japon]TNF inhibitors induce discoid fibrosis in the sublining layers of the synovium with degeneration of synoviocytes in rheumatoid arthritis
000306 (2013) Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
000463 (2010) Luis Rodríguez-Rodríguez [Espagne] ; José Ram N Lamas [Espagne] ; Jezabel Varadé [Espagne] ; Pedro L Pez-Romero [Espagne] ; Pilar Tornero-Esteban [Espagne] ; Lydia Abasolo [Espagne] ; Emilio Gomez De La Concha [Espagne] ; Juan Angel Jover [Espagne] ; Elena Urcelay [Espagne] ; Benjamín Fernández-Gutiérrez [Espagne]Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity
000495 (2013) I. Yokoe [Japon] ; H. Kobayashi [Japon] ; H. Sato [Japon] ; A. Nishiwaki [Japon]AB0539 Comparison of RA patients in tocilizumab (TCZ) therapy who showed only DAS28(ESR) remission and both DAS28-ESR and SDAI remission
000511 (2011) Stefan Kleinert [Allemagne] ; Hans-Peter Tony [Allemagne] ; Andreas Krause [Allemagne] ; Martin Feuchtenberger [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Constanze Richter [Allemagne] ; Ekkehard Röther [Allemagne] ; Wolfgang Spieler [Allemagne] ; Holger Gnann [Allemagne] ; Bianca M. Wittig [Allemagne]Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
000603 (2013) A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie]AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA)
000639 (2013) A. Kaneko ; N. Takahashi ; D. Kida ; Y. Hirano [Japon] ; H. Ishikawa ; T. Kojima ; N. IshiguroAB0515 Predictors of clinical remission (DAS28CRP<2.6) in patients with RA who were treated with abatacept
000776 (2013) F. J. Navarro-Blasco ; J. M. Sempere ; A. Romero [Espagne]AB0046 Cytokine profile in CD4+ FOXP3+ lymphocytes of RA patients treated with tocilizumab and clinical correlation (DAS28-CPR, rheumatoid factor
000880 (2012) Metin Isik [Turquie] ; Burcin Halacli [Turquie] ; Özgür Atmaca [Turquie] ; Sezgin Etgül [Turquie] ; Smail Do An [Turquie] ; Levent K L Nç [Turquie] ; Meral Çalgüneri [Turquie]Triple DMARD combination for rheumatoid arthritis resistant to methotrexate and steroid combination: a single-center experience
000956 (2009) Larry W. Moreland [États-Unis]Cytokines as Targets for Anti‐inflammatory Agents

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "das" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "das" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    das
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021